Australia's Bod Science soars on successful insomnia drug trial results

Bod Science

06/09/2023 05:32

** Shares of Bod Science  BOD.AX  jump as much as 22.4% to
A$0.082, hitting their highest level since Aug. 29
    ** Stock last up 17.9%, eyes best day since July 26
    ** Cannabis-focused pharmaceuticals co completes successful
Schedule 3 trial of CBD product in soft gel format
    ** Co's CBD 100mg product to help patients with insomnia
    ** Says product can be sold to Australian consumers over the
counter without prescription
    ** Trading vol 2.9x the 30-day avg volume of 270,136 shares
    ** Stock has fallen 55.3% this year, as of last close

 (Reporting by Shivangi Lahiri in Bengaluru)
 ((Shivangi.Lahiri@thomsonreuters.com;))